The Manila Times

Renexxion Ireland Ltd. Announces Issuance of Sixth New U.S. Patent Covering New Naronapride Trihydrate Formulation, Dosage Forms, and Treatment of GI Disorders

Renexxion Ireland Limited ('Renexxion'), a private biopharmaceutical company focused on advancing new therapies for patients ...
News.az

Sony patents AI ghost player that guides gamers or plays parts of games

Sony has secured a patent describing an AI-driven system designed to help players progress through videogames by either ...

SKYX Announces Collaboration with NVIDIA on its Connect Program, Cloud, and AI Ecosystem for its Patented Ceiling All-In-One Smart Home Platform and Hub

SKYX expects to include its all-in-one smart platform and hub, in collaboration with NVIDIA’s AI features, in future U.S. and ...

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

New ADHD pipeline leverages TAAP and MPAR technologies to improve safety for patients ~ SAN DIEGO, CALIFORNIA / / January 8, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" ...
The Manila Times

AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)

AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...

BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook

Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets ...

Aclarion Provides 2025 Update and 2026 Corporate Outlook

Quarterly Nociscan scan volumes increased 114% year-over-year in Q4 2025Annual Nociscan scan volumes increased 69% year-over-year in 2025Debt-free balance sheet with $12.0 million in cash as of ...